On behalf of the organising team, I would like to invite you to participate to the 13th Immunotherapy of Cancer Conference (ITOC13), taking place on March 4 – 6, 2027 in Munich, Germany.

ITOC brings together researchers and clinicians to exchange findings and discuss advances in cancer immunotherapy. We would greatly appreciate your support in sharing the conference information with your members through your newsletter, website, event calendar or social media channels.

Abstract submission is now open! We warmly welcome submissions from your members and encourage them to contribute their research to the scientific programme. Accepted abstracts will be published in a supplement to the Journal for ImmunoTherapy of Cancer, with selected contributions presented orally.

Please highlight these key dates to your members:

• Abstract submission deadline: 4 January 2027, 23:59 CET
  Abstract information and submission guidelines
• Early-bird registration deadline: 1 February 2027
  Payment must be received by this date to benefit from the reduced fees.
  Registration information